Amsterdam, Netherlands

Danïel Michiel Go

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Aimm Therapeutics B.v., Kling Biotherapeutics B.v.. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Danïel Michiel Go. Retrieved from https://idiyas.com/inventor/danïel-michiel-go

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Danïel Michiel Go: Innovator in Therapeutic Antibodies

Introduction

Danïel Michiel Go is a prominent inventor based in Amsterdam Zuidoost, Netherlands. He has made significant contributions to the field of biotherapeutics, particularly in the development of novel therapeutic antibodies. With a total of 2 patents to his name, Go is recognized for his innovative approaches to medical treatments.

Latest Patents

Among his latest patents is the "Therapeutic anti-CD9 antibody." This invention provides novel binding compounds and therapeutic applications thereof. The focus on anti-CD9 antibodies highlights his commitment to advancing therapeutic options in the medical field.

Career Highlights

Danïel Go has worked with notable companies such as Kling Biotherapeutics B.V. and Aimm Therapeutics B.V. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Some of his coworkers include Hergen Spits and Paula Maria Wilhelmina Van Helden. Their collaborative efforts have played a crucial role in the success of various projects and innovations.

Conclusion

Danïel Michiel Go is a distinguished inventor whose work in therapeutic antibodies is paving the way for new medical treatments. His contributions to the field are invaluable, and his ongoing research promises to yield further advancements in biotherapeutics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…